首页|期刊导航|新医学|慢性鼻窦炎复发风险分层与长期管理:2026年中山论坛专家观点

慢性鼻窦炎复发风险分层与长期管理:2026年中山论坛专家观点OA

Recurrence risk stratification and long-term management of chronic rhinosinusitis:expert perspectives from the 2026 Zhongshan Forum

中文摘要英文摘要

慢性鼻窦炎(CRS)是耳鼻咽喉科常见慢性炎症性疾病,具有病程迁延、临床异质性强、复发风险高和长期疾病负担重等特点.随着炎症内型、鼻内镜手术、生物制剂、数字化随访和人工智能(AI)技术的发展,CRS管理正从以症状和影像为主的经验化诊疗,转向以风险分层、精准干预和全生命周期管理为核心的综合模式.2026年慢性鼻窦炎中山论坛围绕难治性和复发性 CRS、炎症内型转化、内镜鼻窦手术(ESS)与生物制剂治疗排序、基层规范化诊疗、智能化随访和科研转化等问题开展专题讨论.文章在整合论坛专家观点的基础上,结合国内外指南、立场文件和近年研究证据,提出CRS管理应强化复发风险前移评估、建立分层评估指标体系、优化传统药物、ESS和生物制剂的场景化排序,并以区域协同和数字化工具推动长期慢病管理.与会专家认为,CRS未来诊疗的关键不在于单一新技术替代既有治疗,而在于形成可执行、可评价、可推广的精准诊疗和连续管理体系.

Chronic rhinosinusitis(CRS)is a common chronic inflammatory disease in otorhinolaryngology and is characterized by a prolonged course,substantial heterogeneity,a high recurrence risk in selected patients,and a considerable long-term disease burden.With advances in inflammatory endotyping,endoscopic sinus surgery(ESS),biologics,digital follow-up,and artificial intelligence(AI),CRS care is shifting from an experience-based model relying mainly on symptoms and imaging toward integrated management based on risk stratification,precision intervention,and life-course disease control.The 2026 Zhongshan Forum on Chronic Rhinosinusitis discussed difficult-to-treat and recurrent CRS,clinical translation of inflammatory endotypes,sequencing of ESS and biologics,standardized primary care pathways,intelligent follow-up,and translational research priorities.Based on expert discussions from the forum and current guidelines,position papers,and recent evidence,this article proposes that CRS management should strengthen early recurrence-risk assessment,establish a tiered evaluation system,optimize scenario-based sequencing of conventional pharmacotherapy,ESS,and biologics,and promote long-term chronic disease management through regional collaboration and digital tools.The experts emphasized that the future of CRS care lies not in replacing established therapies with a single new technology,but in building an executable,measurable,and scalable system for precision diagnosis and continuous management.

孙悦奇;杨钦泰;陈枫虹;石照辉;赖银妍;张雅娜;洪海裕;赖明;左可军;史剑波

中山大学附属第六医院,广东 广州 510655中山大学附属第三医院,广东 广州 510630广州医科大学附属第二医院,广东 广州 510260中山大学附属第三医院,广东 广州 510630中山大学附属第一医院,广东 广州 510080中山大学附属第三医院,广东 广州 510630中山大学附属第五医院,广东 珠海 519000广东祈福医院,广东 广州 511495中山大学附属第一医院,广东 广州 510080中山大学附属第一医院,广东 广州 510080

医药卫生

慢性鼻窦炎鼻息肉炎症内型生物制剂内镜鼻窦手术人工智能慢病管理基层医疗

Chronic rhinosinusitisNasal polypsInflammatory endotypeBiologicsEndoscopic sinus surgeryArtificial intelligenceChronic disease managementPrimary care

《新医学》 2026 (9)

927-934,8

国家自然科学基金(82371114)

10.12464/j.issn.0253-9802.2026-0752

评论